|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]pyrazine-2-carbonitrile |
International Nonproprietary Names ![]() |
|
INN number | INN |
10276 | prexasertib |
Synonyms ![]() |
LY2606368 |
Database Links ![]() |
|
CAS Registry No. | 1234015-52-1 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL3544911 |
GtoPdb PubChem SID | 336446935 |
PubChem CID | 46700756 |
Search Google for chemical match using the InChIKey | DOTGPNHGTYJDEP-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | DOTGPNHGTYJDEP |
Search PubMed clinical trials | prexasertib |
Search PubMed titles | prexasertib |
Search PubMed titles/abstracts | prexasertib |
Search UniChem for chemical match using the InChIKey | DOTGPNHGTYJDEP-UHFFFAOYSA-N |
Search UniChem for chemicals with the same backbone | DOTGPNHGTYJDEP |
Comments |
Prexasertib (LY2606368), an investigational small molecule checkpoint kinase 1 (CHK1) inhibitor [2] that exhibits anti-tumour activity in preclinical models of pediatric cancer. |